MINT: opportunities in ‘frontier’ markets?
The prospects for pharma in the MINT emerging countries of Mexico, Indonesia, Nigeria and Turkey.
The prospects for pharma in the MINT emerging countries of Mexico, Indonesia, Nigeria and Turkey.
MINT countries: what the opportunities may be for pharma and healthcare.